PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-20.58%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-40.39%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-41.75%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-41.75%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-63.52%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-63.08%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-62.83%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-1.29%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-1.63%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
13.73%
Maintaining or increasing dividends while CVE cut them. John Neff might see a strong edge in shareholder returns.
22.06%
Positive OCF growth while CVE is negative. John Neff would see this as a clear operational advantage vs. the competitor.
-11.41%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
44.06%
10Y revenue/share CAGR above 1.5x CVE's 16.40%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
54.52%
5Y revenue/share CAGR at 50-75% of CVE's 76.08%. Martin Whitman would worry about a lagging mid-term growth trajectory.
2.64%
3Y revenue/share CAGR under 50% of CVE's 106.27%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
88.97%
Positive long-term OCF/share growth while CVE is negative. John Neff would see a structural advantage in sustained cash generation.
122.94%
Positive OCF/share growth while CVE is negative. John Neff might see a comparative advantage in operational cash viability.
100.66%
Positive 3Y OCF/share CAGR while CVE is negative. John Neff might see a big short-term edge in operational efficiency.
167.57%
Net income/share CAGR above 1.5x CVE's 47.37% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
156.51%
5Y net income/share CAGR similar to CVE's 162.63%. Walter Schloss might see both on parallel mid-term trajectories.
23.02%
Below 50% of CVE's 122.80%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
0.40%
Below 50% of CVE's 12.66%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-7.34%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-17.62%
Negative 3Y equity/share growth while CVE is at 1.52%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
-75.18%
Both reduced dividends long-term. Martin Whitman might check if sector-level headwinds forced universal cuts.
223.44%
5Y dividend/share CAGR above 1.5x CVE's 134.00%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
170.29%
3Y dividend/share CAGR above 1.5x CVE's 82.35%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-16.29%
Firm’s AR is declining while CVE shows 13.54%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
0.45%
Positive asset growth while CVE is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
4.01%
BV/share growth above 1.5x CVE's 1.43%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
4.12%
We have some new debt while CVE reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-12.80%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.